Baran Yusufoğlu

ORCID: 0000-0003-2657-9025
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Radiomics and Machine Learning in Medical Imaging
  • Medical Imaging Techniques and Applications
  • Cancer Diagnosis and Treatment
  • Nutrition and Health in Aging
  • Radiopharmaceutical Chemistry and Applications
  • Lung Cancer Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Thyroid Disorders and Treatments
  • Restraint-Related Deaths
  • Oral health in cancer treatment
  • Lung Cancer Treatments and Mutations

Gulf of Maine Association
2023

Recep Tayyip Erdoğan University
2017

Aim:Skeletal muscle loss is an indicator of cachexia and a strong prognostic factor for some types cancer. After strict standardization, we aim to evaluate both the predictive value low mass (LMM) in common cancer first-line chemotherapy. Methods: This retrospective single-center study was conducted regional hospital between 2015 2020. Patients diagnosed with distant metastatic were screened included if they had abdominal computed tomography 45 days prior The relationship LMM...

10.30565/medalanya.1167930 article EN cc-by-nc-nd Acta Medica Alanya 2023-10-14

Background: PET imaging involves several parameters. However, it is not well known which parameters in each measurable site of tumors may have a greater effect on oncologic outcomes. Method: This study included total 42 patients diagnosed with histology-proven NSCLC. Baseline and consecutive FDG-PET scans were carried out 3 weeks before at least months after treatment, respectively. Results: According to the PERCIST, 9 (21%) had Complete Response (CR), them underwent surgical resection....

10.2174/1573405613666170322155601 article EN Current Medical Imaging Formerly Current Medical Imaging Reviews 2017-03-22

Although positron emission tomography–computed tomography (PET/CT) is widely used for staging, there are limited data available to describe exactly the role of PET/CT metabolic and quantitative parameters prediction disease outcome. A total 145 patients diagnosed with histology-proven lung carcinoma in advanced stage were included. According exclusion criteria remaining 76 (41 them adenocarcinoma EGFR wild-type, 35 squamous non-small cell cancer (NSCLC)) analyzed. Maximum standardized uptake...

10.1016/j.jons.2017.10.003 article EN cc-by-nc-nd Journal of Oncological Sciences 2017-10-14
Coming Soon ...